Education
About Us
Working with TipRanks
Follow Us
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -83.00K | $ -31.00K | $ -35.00K | $ -42.00K | $ -39.00K |
| Operating Income | $ -6.28M | $ 7.49M | $ -17.65M | $ -32.88M | $ -30.21M |
| EBITDA | $ -7.42M | $ -6.87M | $ -17.62M | $ -32.84M | $ -30.17M |
| Net Income | $ -7.52M | $ -6.91M | $ -18.57M | $ -31.95M | $ -27.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.33M | $ 12.64M | $ 13.79M | $ 34.81M | $ 50.89M |
| Total Assets | $ 18.50M | $ 16.63M | $ 16.56M | $ 36.60M | $ 52.38M |
| Total Debt | $ 0.00 | $ 41.00K | $ 44.00K | $ 229.00K | $ 216.00K |
| Net Debt | $ -4.65M | $ -2.82M | $ -1.97M | $ -2.65M | $ -6.73M |
| Total Liabilities | $ 2.17M | $ 2.75M | $ 3.14M | $ 6.11M | $ 8.23M |
| Stockholders' Equity | $ 16.33M | $ 13.88M | $ 13.42M | $ 30.50M | $ 44.15M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.88M | $ -6.14M | $ -18.50M | $ -32.90M | $ -26.33M |
| Operating Cash Flow | $ -5.88M | $ -6.14M | $ -18.50M | $ -32.89M | $ -26.29M |
| Investing Cash Flow | $ -1.11M | $ 800.00K | $ 17.56M | $ 11.46M | $ 16.54M |
| Financing Cash Flow | $ 8.79M | $ 6.18M | $ 70.00K | $ 17.37M | $ 768.00K |